InterventionsHumans

Combination Lipid-Lowering Therapy and the Risks of Various Types of Cancers in Patients with Type 2 Diabetes

ADA Scientific Sessions 2025 Abstract

The paper

HUN KIM S, CHO Y, PARK HS et al.

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Poster 1446-P

doi.org/10.2337/db25-1446-p

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Underweight is linked to higher kidney disease risk in diabetes
Frontiers in Endocrinology · 4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026